Metrogyl New Zealand - English - Medsafe (Medicines Safety Authority)

metrogyl

viatris limited - metronidazole 200mg - tablet - 200 mg - active: metronidazole 200mg excipient: colloidal silicon dioxide disodium edetate ethylcellulose guar gum lactose monohydrate magnesium stearate sodium starch glycolate - metronidazole is indicated in the prophylaxis and treatment of infections in which anaerobic bacteria have been identified or are suspected to be the cause. metronidazole is active against a wide range of pathogenic micro-organisms notably species of bacteroides, fusobacteria, clostridia, eubacteria, anaerobic cocci and gardnerella vaginalis. it is also active against trichomonas, entamoeba histolytica, giardia lamblia and balantidium coli. metronidazole is indicated in adults and children for the following indications: 1. the prevention of postoperative infections due to anaerobic bacteria, particularly species of bacteroides and anaerobic streptococci. 2.the treatment of septicaemia, bacteraemia, peritonitis, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, and post operative wound infections from which pathogenic anaerobes have been isolated. 3. urogenital trichomoniasis in the female (trichomonal vaginitis) and in the male. 4. bacterial vaginosis (also known as non-specific vaginitis, anaerobic vaginosis or gardnerella vaginitis). 5. all forms of amoebiasis (intestinal and extra-intestinal disease and that of symptomless cyst passers). 6. giardiasis. 7. acute ulcerative gingivitis. 8. anaerobically infected leg ulcers and pressure sores. 9. acute dental infections due to anaerobic organisms (e.g. acute pericoronitis and acute apical infections).

Metrogyl New Zealand - English - Medsafe (Medicines Safety Authority)

metrogyl

viatris limited - metronidazole 400mg - tablet - 400 mg - active: metronidazole 400mg excipient: colloidal silicon dioxide disodium edetate ethylcellulose guar gum lactose monohydrate magnesium stearate quinoline yellow sodium starch glycolate - metronidazole is indicated in the prophylaxis and treatment of infections in which anaerobic bacteria have been identified or are suspected to be the cause. metronidazole is active against a wide range of pathogenic micro-organisms notably species of bacteroides, fusobacteria, clostridia, eubacteria, anaerobic cocci and gardnerella vaginalis. it is also active against trichomonas, entamoeba histolytica, giardia lamblia and balantidium coli. metronidazole is indicated in adults and children for the following indications: 1. the prevention of postoperative infections due to anaerobic bacteria, particularly species of bacteroides and anaerobic streptococci. 2.the treatment of septicaemia, bacteraemia, peritonitis, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, and post operative wound infections from which pathogenic anaerobes have been isolated. 3. urogenital trichomoniasis in the female (trichomonal vaginitis) and in the male. 4. bacterial vaginosis (also known as non-specific vaginitis, anaerobic vaginosis or gardnerella vaginitis). 5. all forms of amoebiasis (intestinal and extra-intestinal disease and that of symptomless cyst passers). 6. giardiasis. 7. acute ulcerative gingivitis. 8. anaerobically infected leg ulcers and pressure sores. 9. acute dental infections due to anaerobic organisms (e.g. acute pericoronitis and acute apical infections).

Trichozole New Zealand - English - Medsafe (Medicines Safety Authority)

trichozole

viatris limited - metronidazole 200mg;  ; metronidazole 200mg - tablet - 200 mg - active: metronidazole 200mg   excipient: maize starch dried lactose monohydrate magnesium stearate maize starch microcrystalline cellulose povidone active: metronidazole 200mg excipient: maize starch (5%) lactose monohydrate magnesium stearate maize starch microcrystalline cellulose povidone - metronidazole is indicated in the prophylaxis and treatment of infections in which anaerobic bacteria have been identified or are suspected to be the cause. metronidazole is active against a wide range of pathogenic micro-organisms notably species of bacteroides, fusobacteria, clostridia, eubacteria, anaerobic cocci and gardnerella vaginalis. it is also active against trichomonas, entamoeba histolytica, giardia lamblia and balantidium coli. metronidazole is indicated in adults and children for the following indications: 1. the prevention of postoperative infections due to anaerobic bacteria, particularly species of bacteroides and anaerobic streptococci. 2.the treatment of septicaemia, bacteraemia, peritonitis, brain abcess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, and post operative wound infections from which pathogenic anaerobes have been isolated. 3. urogenital trichomoniasis in the female (trichomonal vaginitis) and in the male. 4. bacterial vaginosis (also known as non-specific vaginitis, anaerobic vaginosis or gardnerella vaginitis). 5. all forms of amoebiasis (intestinal and extra-intestinal disease and that of symptomless cyst passers). 6. giardiasis. 7. acute ulcerative gingivitis. 8. anaerobically infected leg ulcers and pressure sores. 9. acute dental infections due to anaerobic organisms (e.g. acute pericoronitis and acute apical infections).

Trichozole New Zealand - English - Medsafe (Medicines Safety Authority)

trichozole

viatris limited - metronidazole 400mg;  ; metronidazole 400mg - tablet - 400 mg - active: metronidazole 400mg   excipient: maize starch dried lactose monohydrate magnesium stearate maize starch microcrystalline cellulose povidone quinoline yellow sodium starch glycolate active: metronidazole 400mg excipient: maize starch 5% lactose monohydrate magnesium stearate maize starch microcrystalline cellulose povidone quinoline yellow sodium starch glycolate - metronidazole is indicated in the prophylaxis and treatment of infections in which anaerobic bacteria have been identified or are suspected to be the cause. metronidazole is active against a wide range of pathogenic micro-organisms notably species of bacteroides, fusobacteria, clostridia, eubacteria, anaerobic cocci and gardnerella vaginalis. it is also active against trichomonas, entamoeba histolytica, giardia lamblia and balantidium coli. metronidazole is indicated in adults and children for the following indications: 1. the prevention of postoperative infections due to anaerobic bacteria, particularly species of bacteroides and anaerobic streptococci. 2.the treatment of septicaemia, bacteraemia, peritonitis, brain abcess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, and post operative wound infections from which pathogenic anaerobes have been isolated. 3. urogenital trichomoniasis in the female (trichomonal vaginitis) and in the male. 4. bacterial vaginosis (also known as non-specific vaginitis, anaerobic vaginosis or gardnerella vaginitis). 5. all forms of amoebiasis (intestinal and extra-intestinal disease and that of symptomless cyst passers). 6. giardiasis. 7. acute ulcerative gingivitis. 8. anaerobically infected leg ulcers and pressure sores. 9. acute dental infections due to anaerobic organisms (e.g. acute pericoronitis and acute apical infections).

FLAGYL 400 TABLET 400 mg Singapore - English - HSA (Health Sciences Authority)

flagyl 400 tablet 400 mg

sanofi-aventis singapore pte. ltd. - metronidazole - tablet, film coated - 400 mg - metronidazole 400 mg

FLAGYL TABLET 200 mg Singapore - English - HSA (Health Sciences Authority)

flagyl tablet 200 mg

sanofi-aventis singapore pte. ltd. - metronidazole - tablet, film coated - 200 mg - metronidazole 200 mg

BIMZELX SOLUTION Canada - English - Health Canada

bimzelx solution

ucb canada inc - bimekizumab - solution - 160mg - bimekizumab 160mg

BIMZELX SOLUTION Canada - English - Health Canada

bimzelx solution

ucb canada inc - bimekizumab - solution - 160mg - bimekizumab 160mg